Ascendis Pharma Market Sentiment

Ascendis Pharma AS

ASNDNASDAQ

$251.27

-1.73-0.68%

Últ. Act.: Oct 30, 4:00 PM

Panorámica general Noticias Previsión de beneficios Eventos Precios objetivo FinanzasSentimientoPropiedad Comparar Opciones Informe de acciones

Ascendis Pharma Market Sentiment - Benzinga

Ascendis Pharma Market Sentiment

Market sentiment signals for Ascendis Pharma (ASND): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 5.6% short float

Options Flow▲ 0.18 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

24 analysts

Options Flow (P/C)

0.18

More calls — Bullish

34 calls · 6 puts

Avg Consensus PT

$299

+19.0%

Highest Price Target

$344

+36.9%

HC Wainwright & Co.

Lowest Price Target

$181

-28.0%

Wedbush

Short Interest

5.6%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 26, 2026	Citigroup	Eric Joseph—	+31.3%	$360 → $330	Maintained	Buy
Oct 15, 2026	UBS	Joon Lee—	+7.1%	$307 → $269	Assumes	Buy
Sep 25, 2026	Cantor Fitzgerald	Li Watsek—	+19.4%	$300 → $300	Maintained	Overweight
Sep 15, 2026	Raymond James	Martin Auster—	+14.2%	$287 → $287	Downgrade	Strong Buy→Outperform
Sep 2, 2026	Oppenheimer	Leland Gershell—	+24.2%	$304 → $312	Maintained	Outperform
Sep 1, 2026	Morgan Stanley	Maxwell Skor—	+8.6%	$275 → $273	Maintained	Overweight
Sep 1, 2026	Wedbush	Yun Zhong—	+30.1%	$327 → $327	Maintained	Outperform
Aug 31, 2026	B of A Securities	Tazeen Ahmad—	+21.0%	$306 → $304	Maintained	Buy
Aug 31, 2026	Jefferies	Kelly Shi—	+31.3%	$333 → $330	Maintained	Buy
Aug 31, 2026	Stifel	Alex Thompson—	+29.7%	$328 → $326	Maintained	Buy
Aug 31, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+36.9%	$345 → $344	Maintained	Buy
Aug 27, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+37.3%	$345	Initiate	Buy
Aug 19, 2026	BMO Capital	David Lebowitz—	+27.0%	$319	Initiate	Outperform
Aug 14, 2026	TD Cowen	Yaron Werber—	+35.7%	$325 → $341	Maintained	Buy
Aug 14, 2026	RBC Capital	Luca Issi—	+15.4%	$280 → $290	Maintained	Outperform
Aug 14, 2026	Barclays	Eliana Merle—	+30.9%	$345 → $329	Maintained	Overweight
Jul 23, 2026	Morgan Stanley	Maxwell Skor—	+9.4%	$256 → $275	Maintained	Overweight
Jul 7, 2026	RBC Capital	Luca Issi—	+11.4%	$275 → $280	Maintained	Outperform
May 19, 2026	Citigroup	Eric Joseph—	+41.3%	$355	Initiate	Buy
May 15, 2026	Evercore ISI Group	Josh Schimmer—	+30.9%	$324 → $329	Maintained	Outperform
May 11, 2026	Barclays	Eliana Merle—	+37.3%	$342 → $345	Maintained	Overweight
May 8, 2026	Wells Fargo	Derek Archila—	+29.7%	$330 → $326	Maintained	Overweight
Apr 16, 2026	B of A Securities	Tazeen Ahmad—	+16.2%	$262 → $292	Maintained	Buy
Apr 9, 2026	Wedbush	Yun Zhong—	+8.6%	$273 → $273	Maintained	Outperform
Mar 16, 2026	Jefferies	Kelly Shi—	+15.4%	$252 → $290	Assumes	Buy